2026 Miami GU Oncology Summit
Accreditation: 5.00 Nursing Contact Hours | 5.00 ABIM MOC II | 5.00 AMA PRA Category 1 Credit™ | 5.00 ACPE Pharmacy
Venue: Hyatt Regency Miami, 400 Southeast 2nd Street, Miami, FL, 33131, United States
Official conference page for 2026 Miami GU Oncology Summit. https://binaytara.org/projects/conferences/2026-miami-gu-oncology-summit
About 2026 Miami GU Oncology Summit


Faculty and committee
Our Speakers
Planning Committee
Faculty
Conference program and agenda
Agenda
Saturday, November 14th, 2026
All timings are in Eastern Time (EST, GMT-05:00) time.
Session Chairs: Rohan Garje, MD; Michael Carducci, MD
08:30 AM - 08:45 AM
Case Presentation: The Case for Upfront PSMA Radioligand Therapy: Should Pluvicto Become the First-Line Standard for All PSMA-Positive Prostate Cancer? – Jordan Alana Ciuro, MD
08:45 AM - 09:00 AM
Case Presentation: The Case for Chemotherapy Intensification: When is ADT + ARPI + docetaxel the Preferred First-Line Triplet in mAPMN/S Prostate Cancer? – Janaki Sharma, MD
09:00 AM - 09:15 AM
Case Presentation: Upfront PARP Inhibition in mAPMN/S Prostate Cancer: Is BRCA2 the Defining Biomarker, and Who Benefits Beyond It? – Umang Swami, MD
09:15 AM - 09:30 AM
Case Presentation: Capivasertib + abiraterone + ADT in PTEN-Deficient mAPMN/S Prostate Cancer: Defining the Ideal Candidate? – Jingsong Zhang, MD, PhD
09:30 AM - 09:50 AM
Case-Based Panel Discussion
Moderators:
Rohan Garje, MD; Michael Carducci, MD
Panelists:
Vinay Minocha, MD; Jordan Alana Ciuro, MD; Janaki Sharma, MD; Umang Swami, MD; Jingsong Zhang, MD, PhD
Session Chairs: Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD
09:50 AM - 10:05 AM
Case Presentation: The Localized Renal Mass: Surgery, Ablation, Radiation, or Surveillance? – Jonathan Silberstein, MD
10:05 AM - 10:20 AM
Case Presentation: Adjuvant Therapy After Nephrectomy: Who Should We Treat and With What? – Ulka Vaishampayan, MD
10:20 AM - 10:35 AM
Case Presentation: Optimal First-Line Systemic Therapy for Metastatic Clear-Cell RCC and the Role of Cytoreductive Nephrectomy – Tianshi Liu, MD
10:35 AM - 10:50 AM
Case Presentation: Non–Clear-Cell RCC: Histology, Molecular Drivers, and Treatment Selection – Rafael Arteta-Bulos, MD
10:50 AM - 11:10 AM
Case-Based Panel Discussion
Moderators:
Daniel Vilarim Araujo, MD; Leonardo D. Borregales, MD
Panelists:
Raju Vaddepally, MD; Jonathan Silberstein, MD; Ulka Vaishampayan, MD; Tianshi Liu, MD; Rafael Arteta-Bulos, MD
Session Chairs: Arnab Basu, MBBS, MPH; Manuel Ozambela, MD
11:25 AM - 11:40 AM
Case Presentation: Updates in the Management of NMIBC – Indraneel Banerjee, MD, MBBS
11:40 AM - 11:55 AM
Case Presentation: Perioperative Systemic Therapy for MIBC - A Moving Target – Rohit Jain, MD, MPH
11:55 AM - 12:10 PM
Case Presentation: Front-Line Treatment of Metastatic Urothelial Carcinoma – Vitor Fiorin De Vasconcellos, MD, PhD
12:10 PM - 12:25 PM
Case Presentation: Treatment Options After EVP – Spencer Henick Bachow, MD
12:25 PM - 12:45 PM
Case-Based Panel Discussion
Moderators:
Arnab Basu, MBBS, MPH; Manuel Ozambela, MD
Panelists:
Jan Krzysztof Rudzinski, MD; Indraneel Banerjee, MD, MBBS; Rohit Jain, MD, MPH; Vitor Fiorin De Vasconcellos, MD, PhD; Spencer Henick Bachow, MD
Session Chairs: Alena Karotkina, APRN; Kristine Landrian, DO
01:30 PM - 01:45 PM
Case Presentation: Symptom Management – Kristine Landrian, DO
01:45 PM - 02:00 PM
Case Presentation: Drug Interaction – Isabel Houlzet, PharmD, BCOP
02:00 PM - 02:15 PM
Case Presentation: Role of Research Coordinator in Clinical Trials – Leslie V Castaneda, MPH, MA
02:15 PM - 02:35 PM
Case-Based Panel Discussion
Moderators:
Kristine Landrian, DO; Alena Karotkina, APRN
Panelists:
Isabel Houlzet, PharmD, BCOP; Leslie V Castaneda, MPH, MA
